Cobo Technologies ApS. (4/23/19). "News: Welcome to Our New COO, Hasse Herlevsen".

	Organisation	Cobo Technologies ApS
	Organisation 2	Leo Pharma A/S
	Group	Leo Pharma (Group)
	Product	PIPPR® protein expression analysis platform
	Product 2	quality control diagnostics
	Index term 2	United States (govt)–Cobo Technologies: genome editing, 201904– collab Cobo beomes member of NIST Genome Editing Consortium
	Person	Herlevsen, Hasse (Cobo Technologies 201904– COO + Co-Owner before Leo Pharma)

To further strengthen our expertise within the Quality Control field, Hasse Herlevsen (former Corp. VP Quality, LEO Pharma) will join our team as COO.

Hasse will be responsible for the daily operation including all internal/external QC related projects. In addition he will also lead our membership in the NIST - Genome Editing Consortium and advise customers about standards and guidelines within the CRISPR Medicine field.

Record changed: 2019-07-09

Picture [iito] Plain Stupid Simple 650x80px

More documents for Cobo Technologies ApS

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]